Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31139750 | 0.89 | MEN1 (0.48) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139760 | 0.87 | MEN1 (0.46) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139868 | 0.82 | MEN1 (0.43) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139768 | 0.82 | MEN1 (0.54) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139730 | 0.82 | MEN1 (0.46) | MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL31139729 | 0.80 | KMT2A (0.47) | MEN1KMT2ARAB9AKDM4EALDH1A1 | |
| SCHEMBL31139720 | 0.77 | MEN1 (0.53) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139765 | 0.77 | MEN1 (0.53) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139719 | 0.77 | MEN1 (0.53) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL31139732 | 0.77 | MEN1 (0.51) | MEN1KMT2ANPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118696034-A | Novel bicyclic compounds as RAD51 inhibitors | 萨提亚疗法股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118696034-A | Novel bicyclic compounds as RAD51 inhibitors | 萨提亚疗法股份有限公司 | 2024-09-24 | — | — | CN | disclosed |